Phase II clinical trial with 5-fluorouracil, recombinant interferon-α-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus
Scott Wadler, Hilda Haynes, Jonathan J. Beitler, Xiaoping Hu, Stanley Fell, Margarita Camacho, Barry Levine, Peter H. Wiernik
Dive into the research topics of 'Phase II clinical trial with 5-fluorouracil, recombinant interferon-α-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus'. Together they form a unique fingerprint.